MDMA’S 25TH ANNUAL REIMBURSEMENT & HEALTH POLICY CONFERENCE
November 9, 2022
In-person
WASHINGTON D.C.
,
BIOUTAH MEMBERS GET $100 OFF AT THE 2022 REIMBURSEMENT AND HEALTH POLICY CONFERENCE
MDMA is the leading voice for innovative and entrepreneurial medical devices companies, and this year’s Reimbursement & Health Policy Conference will deliver key insights on MedTech reimbursement and market access issues.
- MDMA Members – $695
- State Members – $795 (Members of BioUtah use code “STATE”)
- Non-Members – $895
Recent News
- Biolexis Therapeutics Advances Breakthrough GLP-1 and AMPK Programs into First-in-Human Clinical Trials
- Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
- NUSANO STABLE ISOTOPE PROGRAM ENRICHES GADOLINIUM-160 TO 99.2% PURITY
- CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
